The Claim
Multimodal screening for ovarian cancer has a sensitivity of 83.8% and specificity of 99.8% for detecting cancers diagnosed within one year of testing, whereas ultrasound-only screening has a sensitivity of 72.2% and specificity of 99.5%, indicating that multimodal screening identifies a higher proportion of true cancers while both methods maintain high accuracy in correctly identifying those without cancer.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When checking for ovarian cancer, using a combination of tests finds more cancers early than using just an ultrasound, but both methods are really good at saying you don’t have cancer when you really don’t.
See the scientific wording
The sensitivity of multimodal screening for ovarian cancer detected within one year of testing is 83.8%, with a specificity of 99.8%, while ultrasound-only screening has a sensitivity of 72.2% and specificity of 99.5%, indicating that multimodal screening detects more cancers but both methods have high accuracy in ruling out disease.
What the research says
1 studyThe study checked two ways to find ovarian cancer early: one uses a blood test plus ultrasound, and the other uses ultrasound alone. It found that the blood-plus-ultrasound method caught more cancers (83.8% vs 72.2%) and both were very good at saying you didn’t have cancer (99.8% vs 99.5%), which is exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.